Answers are grounded in this paper and cite their sources.
Topical eye drops containing alkaline hydrophobic drugs such as naphazoline and chlorphenamine are widely used for symptomatic treatment of ocular surface diseases, but rapid precorneal clearance results in short residence times, large peak-valley fluctuations and a need for frequent dosing. Hyaluronic acid nanocomposites could improve retention, yet most physical methods to form drug-hyaluronic acid complexes rely on water-miscible organic solvents, leading to drug precipitation, heterogeneous loading and residual-solvent concerns. Here, we developed a simple carbonic acid-enabled hyaluronan nanocomposite (NC-CEHN) system as a green route for ocular delivery of alkaline hydrophobic drugs. Naphazoline and chlorphenamine were converted to their free bases, dissolved in carbon dioxide (CO2)-saturated water (pH 5-6) and mixed with an aqueous low-molecular-weight hyaluronic acid solution. Importantly, CO2 served as a reversible, green acidifying agent that transiently solubilized the drug free bases in fully aqueous media and, upon mild degassing, drove their ionic complexation with hyaluronan without any water-miscible organic solvents. Removal of carbonic acid by mild heating followed by high-pressure homogenization yielded sub-200-nm particles with a moderately negative zeta potential. Differential scanning calorimetry and X-ray diffraction showed the disappearance of drug crystalline peaks, indicating amorphous or molecular dispersion within the hyaluronic acid matrix. NC-CEHN displayed suitable viscosity and drop weight, sustained in vitro release without a pronounced burst, and good physical stability on storage at 4°C. In vivo and ex vivo studies demonstrated prolonged precorneal retention and stronger, more homogeneous penetration into corneal/conjunctival tissues compared with an aqueous naphazoline and chlorphenamine solution with the same hyaluronic acid concentration, while slit-lamp examination and irritation scoring revealed no obvious ocular irritation. These findings suggest that CO2-assisted hyaluronic acid nanocomposites provide a green, eye-dropper-compatible approach for formulating alkaline hydrophobic drugs into long-acting ocular preparations and may offer a useful basis for extending this concept to other cationic hydrophobic drugs.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: